SAMLYN CAPITAL, LLC

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 1421097 New York, NY

Position in DNTH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$36,179,169

New position

Shares Held

431,115

first reported quarter

Ownership

0.789%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SAMLYN CAPITAL, LLC holds $261,566,172 across 7 Biotechnology names. DNTH ranks #3 (13.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	417,205	$68,221,360
2	RCUS	Arcus Biosciences, Inc.	1,908,412	$41,221,696
3	DNTH	Dianthus Therapeutics, Inc. /DE/ This page	431,115	$36,179,169
4	RVMD	Revolution Medicines, Inc.	371,948	$36,171,943
5	DYN	Dyne Therapeutics, Inc.	1,922,543	$34,855,702
6	TERN	Terns Pharmaceuticals, Inc.	472,472	$24,908,722
7	SYRE	Spyre Therapeutics, Inc.	396,661	$20,007,580

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$36,179,169	431,115	—	Shares	Defined	2026-05-15
No filing history on record for this holder in this stock.